Knockdown of SOX2 in GSCs of human glioblastoma, a grade IV glioma and most common primary brain tumour, ceased cell proliferation and tumourigenicity in immunodeficient mice [89]. The gene discussed is SOX2; the disease is central nervous system cancer.